Brain structural alterations in MOG antibody diseases: a comparative study with AQP4 seropositive NMOSD and MS

Abstract

MOGAD demonstrated cortical and subcortical atrophy without severe WM rarefaction. The subcortical GM volume correlated with clinical disability and a combination of MRI and clinical measures could separate MOGAD from AQP4+ NMOSD and MS.